India Cuts Price of Cancer Drug, Calls Consumers to Report Overcharging

The government today announced a significant price cut for a widely used cancer drug, aiming to make the medication more affordable for patients across the country.
The reduction comes as part of a broader effort to curb high drug costs and improve access to essential treatments.
Health officials have urged consumers to report any instances of overcharging, warning that some pharmacies may still charge the old, higher rates.
The move follows recent regulatory reviews that highlighted the need for tighter price controls on life‑saving medicines.